1995
DOI: 10.1164/ajrccm.152.6.8520769
|View full text |Cite
|
Sign up to set email alerts
|

The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation.

Abstract: Exercise in chronic airflow limitation (CAL) is often limited by symptoms before the physiologic boundaries of maximal ventilatory or cardiovascular capacities are attained. Symptom amelioration should translate directly into improved exercise performance. We studied the impact of a 6-wk supervised multimodality endurance exercise program (EXT) on perceived breathlessness (B) and leg effort (LE) and sought a physiologic rationale for symptom improvement. Thirty patients with CAL (FEV1/FVC = 42 +/- 2%, mean +/-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
79
1
15

Year Published

2001
2001
2011
2011

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 179 publications
(98 citation statements)
references
References 34 publications
3
79
1
15
Order By: Relevance
“…Clearly, COPD patients assigned to tiotropium were able to perform this demanding physical task with less respiratory discomfort (at standardised levels of exercise despite higher levels of ventilation) and over a longer duration. The magnitude of effect of tiotropium on ET and dyspnoea is comparable to that achieved using a similar exercise protocol with other proven dyspnoea-relieving interventions, such as oxygen [36], lung volume reduction surgery [37] and exercise training [38], suggesting a clinically important response. Improvements in the exertional dyspnoea ratings at isotime after 42 days of tiotropium occurred in tandem with the improved TDI, a measure of activity-related dyspnoea, again suggesting that acute improvements in the laboratory translate into important long-term effects in the home [32].…”
Section: Clinical Significance Of Laboratory Exercise Testing Resultsmentioning
confidence: 52%
“…Clearly, COPD patients assigned to tiotropium were able to perform this demanding physical task with less respiratory discomfort (at standardised levels of exercise despite higher levels of ventilation) and over a longer duration. The magnitude of effect of tiotropium on ET and dyspnoea is comparable to that achieved using a similar exercise protocol with other proven dyspnoea-relieving interventions, such as oxygen [36], lung volume reduction surgery [37] and exercise training [38], suggesting a clinically important response. Improvements in the exertional dyspnoea ratings at isotime after 42 days of tiotropium occurred in tandem with the improved TDI, a measure of activity-related dyspnoea, again suggesting that acute improvements in the laboratory translate into important long-term effects in the home [32].…”
Section: Clinical Significance Of Laboratory Exercise Testing Resultsmentioning
confidence: 52%
“…2). It is likely that the reduction in ventilatory requirement is multifactorial and relates to improved oxidative capacity [4,25], altered breathing pattern [6] and/or improved work efficiency [26]. The significant training-induced increase in LT is probably indicative of improved efficiency of peripheral muscle oxygen extraction [4,27].…”
Section: Discussionmentioning
confidence: 99%
“…2). The reduction in fR by 16 and 15% in the IT and CT groups, respectively, would be expected to reduce thoracic gas entrapment and the rate of expiratory muscle recruitment and result in decreased work of breathing and exertional breathlessness [26]. It is also likely that the reduction in ventilatory requirement following IT is associated with a reduced metabolic requirement and recruitment of active muscle mass [20] and hence an improvement in mechanical efficiency, shown by the reduction in the slope of V9O 2 /WR ( fig.…”
Section: Discussionmentioning
confidence: 99%
“…the improvement in V9O 2 ,peak after rehabilitation in COPD), particularly in patients with the most advanced disease. In some controlled studies, V9O 2 ,peak increased significantly [255][256][257][258], while other studies failed to observe a significant amelioration [259,260]. hL has also been used as an outcome variable, particularly in CHF patients.…”
Section: Symptom-limited Incremental Testmentioning
confidence: 99%